Other languages Gencurix Inc.

Equities

A229000

KR7229000005

End-of-day quote Korea S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
2,945 ^KRW	-1.17%		-4.38%	-52.65%

15/04	J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion.	CI
03/04	J&L Agent Co., Ltd. and other buyer agreed to acquire 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3.2 billion.	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

J&L Agent Co., Ltd. and other buyer completed the acquisition of 4.97% stake in NGeneBio Co., Ltd. from Gencurix Inc. for KRW 3 billion.	15/04
Gencurix Inc. Obtains Approval for Companion Diagnostic of Digital Pcr-Based Egfr Mutation Test	14/23/14
Gencurix Announces Clinical Research Results at Asco Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, Oncotypedx	07/23/07
Gencurix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12
Gencurix Announces Korean and Japanese Cancer Patients' 15-Year Follow-Up Prognostic Test Clinical Results	10/23/10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer